Gatifloxacin-Associated Corrected QT Interval Prolongation, Torsades de Pointes, and Ventricular Fibrillation in Patients with Known Risk Factors

Joseph Bertino, Robert C. Owens, Timothy D. Carnes, Paul B. Iannini

Clinical Infectious Diseases · 2002 · 57 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

Drugs not commonly considered to be cardioactive agents have been reported to cause prolongation of the corrected QT interval with resultant torsades de pointes or ventricular fibrillation. We report 4 cases of gatifloxacin-associated cardiac toxicity in patients with known risk factors for this adverse event.

References

6